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Abstract
Background: In a cross-sectional study we examined whether the haemodynamic response to upright posture
could be divided into different functional phenotypes, and whether the observed phenotypes were associated with
known determinants of cardiovascular risk.
Methods: Volunteers (n = 470) without medication with cardiovascular effects were examined using radial pulse
wave analysis, whole-body impedance cardiography, and heart rate variability analysis. Based on the passive
head-up tilt induced changes in systemic vascular resistance and cardiac output, the principal determinants of
blood pressure, a cluster analysis was performed.
Results: The haemodynamic response could be clustered into 3 categories: upright increase in vascular resistance
and decrease in cardiac output were greatest in the first (+45 % and -27 %, respectively), smallest in the second
(+2 % and -2 %, respectively), and intermediate (+22 % and -13 %, respectively) in the third group. These groups
were named as ‘constrictor’ (n = 109), ‘sustainer’ (n = 222), and ‘intermediate’ (n = 139) phenotypes, respectively. The
sustainers were characterized by male predominance, higher body mass index, blood pressure, and also by higher
pulse wave velocity, an index of large arterial stiffness, than the other groups (p < 0.01 for all). Heart rate variability
analysis showed higher supine and upright low frequency/high frequency (LF/HF) ratio in the sustainers than
constrictors, indicating increased sympathovagal balance. Upright LF/HF ratio was also higher in the sustainer than
intermediate group. In multivariate analysis, independent explanatory factors for higher pulse wave velocity were
the sustainer (p < 0.022) and intermediate phenotypes (p < 0.046), age (p < 0.001), body mass index (p < 0.001), and
hypertension (p < 0.001).
Conclusions: The response to upright posture could be clustered to 3 functional phenotypes. The sustainer
phenotype, with smallest upright decrease in cardiac output and highest sympathovagal balance, was
independently associated with increased large arterial stiffness. These results indicate an association of the
functional haemodynamic phenotype with an acknowledged marker of cardiovascular risk.
Trial registration: ClinicalTrials.gov NCT01742702
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Background
Elevated blood pressure (BP) and related cardiovascular
(CV) complications are leading causes of morbidity and
mortality, and early recognition of individuals with in-
creased CV risk is of foremost importance [1]. All new
cases of CV disease cannot be predicted using classical
risk factors like family history, obesity, smoking, hyper-
tension, diabetes, or dyslipidaemias. Therefore, studies
aiming at the discovery of novel risk factors are still
needed [2, 3]. Furthermore, also psychosocial factors,
like hostility and anger, have been linked with worse car-
diovascular outcome [4].
The CV phenotype in clinical practice has mainly been
determined by measuring brachial BP and HR, even
though the value of repeated single BP measurements in
the diagnosis of hypertension has been questioned [5, 6].
The haemodynamic changes causing similar elevations
of BP may differ between patients and disorders. For ex-
ample, systemic vascular resistance is typically elevated
in essential hypertension [7], while changes in fluid and
electrolyte balance are characteristic causes of elevated
BP during chronic kidney disease [8].
The age-related decrease in large arterial compliance
is accelerated in various CV disorders [9, 10]. Increased
large arterial stiffness is an acknowledged CV risk factor
in both general populations and subjects with medical
disorders [9, 11]. Increased arterial stiffness also predis-
poses to exaggerated upright decrease in central BP and
orthostatic hypotension [12, 13]. The determination of
pulse wave velocity (PWV) is the gold standard when
evaluating large arterial stiffness [10].
The assessment of CV status is usually performed at
rest, but several studies have shown that haemodynamic
reactivity to physical stimuli provides further informa-
tion about CV risk. Enhanced BP response to cold
pressor test, or to 4-min 2-step exercise test, predicted
the development of hypertension in Japanese popula-
tions [14, 15]. Reduced heart rate (HR) recovery after bi-
cycle ergometer testing predicted mortality in a Finnish
study [6]. As the change in body posture from supine to
upright induces changes in autonomic tone and arterial
resistance, orthostatic challenge can also be regarded as
a stress test addressing CV reactivity [16, 17].
In the course of our studies on haemodynamics, we
have observed that there are reproducible individual var-
iations in the changes in cardiac output and systemic
vascular resistance in response to upright posture [17–
19]. The objective of the present study was to examine
the hypothesis whether functional differences exist in
CV responses to upright posture, and whether these dif-
ferences are associated with known determinants of car-
diovascular risk. The results show that not only age,
body mass index (BMI), and the presence of hyperten-
sion, but also the phenotype of the haemodynamic




All subjects participated in an ongoing study on haemo-
dynamics (clinical trials registration NCT01742702). An
announcement for recruitment was distributed at the
Tampere University Hospital, University of Tampere,
local occupational health care providers, Varala Sports
Institute, and two announcements were published in a
newspaper. By the time of the present analysis, 694 sub-
jects had been recruited. The participants were inter-
viewed and examined by a physician. Subjects with
diabetes, coronary artery disease, cardiac insufficiency,
atherosclerotic vascular disease, cerebrovascular disease,
renal disease, or medication influencing CV status were
excluded.
Ethics, consent and permissions
All participants gave written informed consent and the
study was approved by the ethics committee of Tampere
University Hospital District (study number R06086M).
The investigation conforms to the principles outlined in
the Declaration of Helsinki.
Laboratory analyses
Blood and urine samples were obtained after about 12 h
of fasting. Plasma sodium, potassium, calcium, glucose,
creatinine, triglyceride, and total, high-density and low-
density lipoprotein cholesterol concentrations were de-
termined using Cobas Integra 700/800 or Cobas 6000,
module c501 (F. Hoffmann-LaRoche Ltd, Basel,
Switzerland), and blood cell count by ADVIA 120 or
2120 (Siemens Healthcare GmbH, Erlangen, Germany).
Estimated glomerulus filtration rate (eGFR) was calcu-
lated using the Modification of Diet in Renal Disease
(MDRD) formula [20].
Pulse wave recording
An automatic tonometric sensor on the left wrist was used
to continuously capture radial BP and pulse wave form
(Colin BP-508 T, Colin Medical Instruments Corp., USA).
The radial BP signal was calibrated every 2–4 min by
contralateral brachial BP measurements [12, 17, 21, 22].
Whole-body impedance cardiography
Changes in body electrical impedance during cardiac cy-
cles were recorded using whole-body impedance cardi-
ography (CircMonR, JR Medical Ltd., Tallinn, Estonia) to
determine HR, stroke volume, and cardiac output, as
previously described [23–25]. Cardiac output and stroke
volume were related to estimated body surface area to
derive cardiac index (l/min/m2) and stroke index (ml/
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m2). Systemic vascular resistance index (SVRI, dyn*s/
cm5*m2) was calculated from tonometric BP signal and
cardiac index. In supine position and during head-up tilt,
the cardiac output values of CircMonR are in good
agreement with values measured using thermodilution
[23, 24].
PWV was determined using whole-body impedance
cardiography [25, 26]. As the impedance-based method
slightly overestimates PWV when compared with Dop-
pler ultrasound method, a validated equation was ap-
plied to calculate values that correspond to the
ultrasound method (PWV = (PWVimpedance *0.696) +
0.864) [25].
The method for PWV measurement using whole body
ICG has been described previously [25, 26]. Briefly, the
distal impedance is recorded from popliteal artery at
knee joint level, and the active electrode is placed on the
lateral side of the knee and the reference electrode on
the calf below knee. When the pulse pressure wave en-
ters the aortic arch and the diameter of the aorta
changes, the whole-body impedance decreases, and this
is measured by the voltage electrodes. To calculate the
PWV value, the CircMon software measures the time
difference between onset of the decrease in impedance
in the whole-body impedance signal and the popliteal ar-
tery signal (aortic-popliteal PWV). The aortic-popliteal
impedance cardiography measurement of PWV has been
validated against aortic-popliteal PWV measurements
using Doppler ultrasound [25]. The PWV results ob-
tained using CircMon show good repeatability, and nor-
mal values for PWV in 799 individuals (age 25–76 years)
have been published [26]. We have also shown that the
determination of stroke volume using impedance cardi-
ography versus 3-dimensional echocardiography show
good correlation [19]. In addition, we have performed
carotid-femoral PWV measurements using applanation
tonometry and compared them with ICG measurements
of aortic-popliteal PWV, and the correlation between
these methods was excellent (r = 0.82).
Frequency domain analysis of heart rate variability (HRV)
HRV analysis was used to assess cardiac autonomic tone.
The electrocardiograms were recorded by the CircMonR
device at 200 Hz sampling rate, and data analyzed using
Matlab software (MathWorks Inc., Natick, Massachu-
setts, USA). Normal R-R intervals were recognized, and
a beat was considered ectopic if the interval differed
more than 20 % from the previous values. The artifacts
were processed using the cubic spine interpolation
method [27]. The following frequency domain variables
were calculated using the Fast Fourier Transformation
method: i) power in low frequency (LF) range (0.04–
0.15 Hz), ii) power in high frequency (HF) range (0.15–
0.40 Hz), and iii) LF/HF ratio [28].
Experimental protocol
Caffeine containing products, smoking and a heavy meal
for at least 4 h, and alcohol for at least 24 h prior to the
investigation were to be avoided. Data was captured in a
temperature-controlled laboratory by research nurses
[12, 17, 22]. The left arm with the tonometric sensor
was abducted 90 degrees in an arm support, which held
it at the level of the heart in supine and upright posi-
tions. The recording comprised continuous capture of
data during three consecutive 5-min periods (total
15 min): 5 min supine, 5 min of head-up tilt to 60 de-
grees, 5 min supine. The repeatability and reproducibil-
ity of the supine and upright measurements are good
[22].
Classification into phenotypes by means of clustering
SVRI and cardiac index were chosen for the phenotypic
classification, since peripheral arterial resistance and cardiac
output are the principal determinants of BP [17, 23, 29]. To
characterize the reaction to upright posture, the differences
in SVRI and cardiac index between supine values (5th mi-
nute average) and upright values (8th and 10th minute av-
erages) were examined. Two values during the head-up tilt
(8th and 10th minute) were chosen to take into account
possible changes during upright posture. To avoid scaling
effects, all differences were standardized to have a mean
value of 0 and a variance of 1. Hierarchical clustering was
performed using Ward’s criterion for squared Euclidean
distances: at first each subject served as a cluster, and at
each step two clusters closest to each other were combined,
until only one cluster remained (R software version 2.14.1
[30]). Based on the dendrogram, the 3 main clusters were
analysed (Fig. 1; classification to clusters I, II and III). We
also formed a practical rule for clustering, which was tested
in a small validation population (Additional file 1).
Statistical analyses
Due to skewed distribution, PWV and HRV parameters
were logarithmically transformed before statistical ana-
lyses. To evaluate the impact of phenotype on PWV, a
L1-regression was fitted using sex, categorized BMI, cat-
egorized age, categorized hypertension, phenotype, inter-
action between sex and phenotype (Model 1); and
fasting plasma lipids and glucose, and haematocrit
(Model 2, with variables of Model 1 included) as vari-
ables. In addition, Model 1 was used to evaluate the im-
pact of phenotype on HRV parameters. BMI, age, and
presence of hypertension were categorized due to lack of
linearity in the data. We performed additional analyses
using continuous variables without categorization to
examine the association of changes in SVRI and cardiac
index with PWV.
There is no accepted cut-off level to define elevated
BP during tilt-table measurements, while office BP is
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usually higher than home BP [5, 31]. As the supine BP
during haemodynamic measurements was on average 8/
12 mmHg (systolic/diastolic) lower than the seated office
BP (n = 470), we applied the accepted cut-off level for
home and ambulatory daytime measurements, i.e. values
≥135/85 mmHg [31], to define hypertension during the
recordings. The same approach was applied previously,
with testing of different cut-off levels [17].
As summary statistics, median and 25th to 75th per-
centile, or mean and standard deviation (SD) or 95 %
confidence intervals (CI) were reported. Kruskal-Wallis
rank sum test, Fisher’s exact test and Wilcoxon rank
sum test were used to compare haemodynamics and
demographics between the phenotypes. All analyses were
performed using R software version 2.14.1 [30].
Results
Study population and average haemodynamic responses
to head-up tilt
The study population consisted of 470 (240 female and
230 male) individuals aged 20–72 years (average
46 years). Average systolic and diastolic BP, SVRI and
cardiac index in all subjects during the 15-min measure-
ment protocol are shown in Fig. 2. In response to up-
right posture, systolic BP slightly decreased and diastolic
BP increased, while SVRI increased by about 15 %, and
cardiac index decreased by about 15 %. Both SVRI and
cardiac index were stabilized during the time-points
chosen for clustering into phenotypes (at 5 min of re-
cording while supine, and at 8 and 10 min of recording
while upright) (Fig. 2).
Classification into phenotypes
The classification to phenotypes was based on the changes
in systemic vascular resistance and cardiac output in re-
sponse to passive head-up tilt. The cluster that was char-
acterised by the greatest increases in SVRI (+45 %) and
the greatest decreases in cardiac index (−27 %) in response
to upright posture was named ‘constrictor’ (Fig. 3a, d).
The cluster characterised by the smallest changes in SVRI
(+2 %) and cardiac index (−2 %), so that these variables
were sustained on corresponding levels in supine and up-
right positions, was named ‘sustainer’ (Fig. 3c, f ). The
cluster with the intermediary changes (+22 %, -13 %, re-
spectively) was named ‘intermediate’ (Fig. 3b, e). The
mean (±SD) head-up tilt -induced changes in SVRI were
+944 (±361), +554 (±197) and +60 (±254) dyn*s/cm5*m2
in the constrictor, intermediate and sustainer phenotypes,
respectively (Additional file 2). The mean changes in car-
diac index were -0.89 (±0.51), -0.37 (±0.29) and -0.06
(±0.46) l/min/m2, respectively (Additional file 2).
Since supine SVRI and cardiac index differed between
the clusters, we performed additional analyses in which
the subjects were classified to three new clusters merely
on the basis of supine levels of SVRI and cardiac index.
These new clusters did not systematically or significantly
correspond to the constrictor, intermediate and sustainer
clusters (data not shown). This indicates that the above
phenotypes were not discovered because of differences
in the resting levels of SVRI and cardiac index between
the groups.
The characteristics and laboratory values of the pheno-
types are shown in Table 1. Age did not differ between
Fig. 1 Clustering to phenotypes. Cluster dendrogram according to hierarchical clustering using Ward’s criterion for the squared Euclidean
distances. Dashed line indicates the cut-off point for the three phenotypic clusters (I, II and III). The classification was based on the changes in
systemic vascular resistance index and cardiac index in response to passive head-up tilt (n = 470)
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the groups (p = 0.216). The gender distribution (p <
0.001), prevalence of laboratory BP ≥135 and/or
≥85 mmHg (p = 0.009), BMI (p < 0.001), and office BP
values (p < 0.008) were different in the phenotypes, i.e.
the sustainers were more likely to be males with elevated
BP and higher BMI than in the other phenotypes
(Table 1). In addition, total and LDL cholesterol and tri-
glycerides were lowest, and HDL cholesterol highest in
the constrictors (Table 1). Fasting plasma glucose values
were lowest in the constrictors, but the mean values
were within the normal range in all groups. Haematocrit
and creatinine concentrations were lowest in the con-
strictors, probably due to the female predominance, but
the eGFR (MDRD-formula) values did not differ be-
tween the phenotypes (Table 1). In analyses adjusted for
differences in gender distribution, prevalence of labora-
tory BP ≥135/85, and BMI, the above differences in total,
LDL, and HDL cholesterol, triglycerides, and haemato-
crit were no more significant between the phenotypes
(p-values for all >0.12).
Detailed haemodynamics and arterial stiffness
The sustainers showed highest supine systolic BP, while
upright systolic BP did not differ between the pheno-
types (Additional files 3 and 4). Constrictors showed nu-
merically lowest supine and upright diastolic BP. Supine
heart rate was lowest and upright heart rate highest in
sustainers, while supine stroke index was numerically
highest and upright stroke index lowest in the constric-
tors (Additional file 3). Subsequently, supine cardiac
index was highest but upright cardiac index was lowest
in the constrictors. Supine SVRI was lowest in the con-
strictors, while upright SVRI was lowest in the sustainers
(Additional file 3, Fig. 3).
Fig. 2 Average haemodynamics during the head-up tilt protocol. Average radial systolic (a) and diastolic (b) blood pressure, systemic vascular
resistance index (c), and cardiac index (d) during the 15-min measurement protocol (5 min supine – 5 min upright – 5 min supine) in all subjects
(n = 470). Mean ± 95 % confidence interval
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Median PWV was different between the phenotypes,
sustainers showing the highest values (7.35, 8.00 and
8.65 m/s in the constrictor, intermediate and sustainer
phenotypes, respectively) (Fig. 4). In multivariate analysis,
sustainer and intermediate phenotypes, high and middle
BMI tertiles, high and middle age tertiles, BP ≥135/
85 mmHg, and interaction between female sex and inter-
mediate phenotype were significant explanatory factors
for supine PWV (Table 2, Model 1). If the laboratory vari-
ables that were different between the phenotypes (plasma
lipids and glucose, haematocrit) were included in the
multivariate model, the outcome was that sustainer and
intermediate phenotype, high and middle BMI tertiles,
high and middle age tertiles, BP ≥135/85 mmHg, inter-
action between female sex and intermediate phenotype,
and plasma triglyceride level were significant explanatory
factors for supine PWV (Table 2, Model 2). In additional
analyses using continuous variables without
categorization, the supine to upright change in cardiac
index was still independently associated with PWV, while
the association between the change in SVRI and PWV
was not significant (Additional file 5).
Heart rate variability in the phenotypes
The HRV variables in supine and upright position
are depicted in Fig. 5. No significant differences were
found between the phenotypes in supine or upright
power in LF range, a variable predominantly reflect-
ing cardiac sympathetic tone [28, 32]. Supine power
in HF range did not differ between the phenotypes,
either. However, upright HF power was highest in
the constrictors, followed by the intermediate pheno-
type, while the sustainer phenotype showed lowest
level, suggesting reduced cardiac parasympathetic
tone [28, 32]. The sympathovagal balance, as
reflected by LF/HF ratio, was higher in supine pos-
ition in the sustainers than in the constrictors, while
upright LF/HF ratio was higher in the sustainers
than in the two other phenotypes (Fig. 5). In all phe-
notypes, LF/HF ratio clearly increased in the upright
position (p < 0.001). When the analyses were adjusted
for differences in sex, BMI, and presence of hyper-
tension, there were no statistically significant differ-
ences in the HRV variables between the phenotypes
(Additional file 6).
Fig. 3 Haemodynamics in the 3 phenotypes in response to upright posture. Systemic vascular resistance index and cardiac index during the
measurement protocol, respectively, in the constrictor (a, d), intermediate (b, e), and sustainer phenotypes (c, f). Mean (bold line) and individual
curves (grey lines)
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Medications used by the subjects
The majority (58 %) of subjects were without any medi-
cations, and none had medication for cardiovascular dis-
orders or diabetes. The established medications used by
the participants were: 75 female subjects on low-dose
hormones (oestrogen, progestin or combination) for
contraception or hormone replacement therapy, 22
treated with antidepressants, 16 with thyroxin, 21 with
intranasal or inhaled corticosteroids, 12 with statins, 11
with proton pump inhibitors, 11 with antihistamines, 5
with non-steroidal anti-inflammatory drugs, and 5 with
glucosamine. Female hormone regimens were used by
31 % of the female subjects, but the proportions of low-
dose hormone users did not differ between the pheno-
types. Only the use of inhaled or intranasal corticoste-
roids (p = 0.038) differed between the groups so that
these compounds were used by 6.4 %, 6.5 % and 2.3 % of
the subjects in the constrictor, intermediate, and sus-
tainer groups, respectively.
Discussion
The evaluation of the CV status only in the supine or
seated position gives rather limited information about
haemodynamics [16, 17, 22]. Although head-up tilt for
5 min is a short period of observation, we found that
haemodynamic adaptation differed between individuals
of similar age who only showed small differences in BP
Table 1 Demographics and laboratory values in the three phenotypes
Variable Constrictor Intermediate Sustainer p-value
Number of subjects 109 139 222
Age (years) 46 (37–53) 46 (38–57) 47 (38–55) 0.216
Female (%) 80 58* 32*† <0.001
BP ≥ 135/85 mmHg (%) in the laboratory 34 42* 51*† 0.009
Body mass index (kg/m2) 23.1 (21.6–25.6) 26.5 (24.1–29.3)* 27.4 (24.8–30.6)* <0.001
Waist circumference (cm)
Female 79 (73–87) 86 (79–97)* 88 (82–99)* <0.001
Male 85 (80–92) 98 (91–99)* 100 (94–107)* <0.001
Smoking (no/present/previous) 66/16/27 90/14/35 121/23/78 0.090
Office systolic BP (mmHg) 134 (119–148) 139 (123–152) 141 (123–157)* 0.007
Office diastolic BP (mmHg) 84 (75–91) 90 (81–98)* 91 (82–99)* <0.001
Haematocrit 0.40 (0.39–0.42) 0.42 (0.39–0.44)* 0.43 (0.41–0.45)*† <0.001
Creatinine (μmol/l) 66 (59–74) 70 (64–80)* 76 (69–84)*† <0.001
eGFR (ml/min/1.73 m2) 89 (80–97) 88 (79–97) 89 (78–99) 0.631
Total Cholesterol (mmol/l) 4.80 (4.20–5.50) 5.20 (4.60–5.80)* 5.20 (4.4–5.8)* 0.018
LDL Cholesterol (mmol/l) 2.45 (2.10–3.18) 3.00 (2.40–3.60)* 3.10 (2.30–3.70)* <0.001
HDL cholesterol (mmol/l 1.78 (1.49–2.13) 1.54 (1.23–1.84)* 1.43 (1.17–1.71)* <0.001
Triglycerides (mmol/l) 0.92 (0.61–1.16) 1.08 (0.82–1.43)* 1.11 (0.76–1.67)*† <0.001
Fasting plasma glucose (mmol/l) 5.2 (4.9–5.4) 5.4 (5.1–5.7)* 5.5 (5.1–5.8)* <0.001
Values are median (25th-75th percentile); BP, blood pressure; eGFR, estimated creatinine-based glomerulus filtration rate using the MDRD formula;23 *p < 0.05
when compared with constrictor phenotype; †p < 0.05 when compared with intermediate phenotype
Fig. 4 Arterial stiffness in the 3 phenotypes. Boxplots depicting
supine pulse wave velocity in the constrictor, intermediate and
sustainer phenotypes. Median (line inside box), 25th to 75th
percentile (box), range (+), and outliers (open circles); *p < 0.05,
**p < 0.01, ***p < 0.001
Tahvanainen et al. BMC Cardiovascular Disorders  (2016) 16:101 Page 7 of 12
(Additional files 2 and 3). The type of haemodynamic re-
action to upright posture was also related to PWV, an
acknowledged measure of large arterial stiffness [9–11].
Previously, the majority of studies utilizing head-up tilt
have been performed to examine the mechanisms of
syncope [33, 34], and differences in upright haemo-
dynamics have not been systematically investigated in
non-syncopal subjects.
Subjects with increased CV risk should be identified
before the manifestations of a clinical disease [1]. In
addition to the classical risk factors, efforts have been
made to identify novel risk factors to increase the sensi-
tivity of risk evaluation. For example, haemodynamic re-
sponses to physical challenge (bicycle exercise test, step
exercise test, cold pressor test) can predict CV outcome
[6, 15, 35]. As change in posture from supine to upright
activates sensory and neurogenic responses in the body,
with subsequent changes in autonomic tone, cardiac
function, and peripheral arterial resistance, passive head-
up tilt can be regarded as a clinical haemodynamic stress
test [12, 16, 17].
Here we used systemic vascular resistance and cardiac
index, the principal determinants of BP [17, 23, 29], in
the classification of haemodynamic response to upright
posture into three phenotypes. The constrictor pheno-
type showed highest increase in SVRI, greatest decrease
in cardiac output, and highest upright HF power as an
indicator of parasympathetic cardiac autonomic tone
[28, 32]. The sustainers showed lowest increase in vascu-
lar resistance and smallest decrease in cardiac output,
and greatest upright LF/HF ratio indicating highest sym-
pathovagal balance [28, 32]. The constrictors were also
characterised by a more favourable CV risk profile than
the sustainers, with lower total and LDL cholesterol, tri-
glycerides and glucose (Table 1). However, in analyses
adjusted for the differences in gender distribution, BMI
and BP, the differences in the lipid and glucose values
were no more significant.
In multivariate analysis including BMI, age, BP, gender,
haematocrit, plasma glucose and lipid profile, the sus-
tainer and intermediate phenotypes were associated with
higher PWV, i.e. increased large arterial stiffness, than
constrictors. Of note, the statistical coefficients relating
the intermediate and sustainer phenotypes to higher
PWV corresponded to those of increased BMI and ele-
vated BP (Table 2). Higher PWV has been recognised as
an independent CV risk factor in hypertensive subjects,
elderly subjects, diabetics, and even in the general popu-
lation [9, 36, 37]. The close relation between PWV and
the well-known CV risk factors, increased BMI and BP,
has been repeatedly shown [17, 38, 39]. As ageing is a
strong determinant of PWV [37, 40], it is important to
note that the average age did not differ between the
three phenotypes in the present study.
In supine position, HRV analysis showed a higher LF/
HF ratio (increased symphatovagal balance) in the sus-
tainers than in the constrictors [28, 32]. Supine SVRI
was also highest in the sustainers, who were charac-
terised by male predominance, and highest BMI and BP,
all factors associated with increased sympathetic tone
Table 2 Analysis of determinants of arterial stiffness
Model 1: Constant 1.83258 Model 2: Constant 1.74717
Variable Coefficient p-value Coefficient p-value
Phenotype: intermediate 0.09103 0.046 0.12729 0.005
Phenotype: sustainer 0.09103 0.022 0.11514 0.005
BMI: middle tertile 0.07742 <0.001 0.07209 0.002
BMI: high tertile 0.12824 <0.001 0.11146 <0.001
Age: middle tertile 0.09143 <0.001 0.08398 <0.001
Age: high tertile 0.23804 <0.001 0.23729 <0.001
Blood pressure ≥135/85 mmHg 0.10273 <0.001 0.08734 <0.001
Female sex 0.03609 0.377 0.08017 0.065
Interaction: female sex and intermediate phenotype −0.11124 0.043 −0.14789 0.007
Interaction: female sex and sustainer phenotype −0.07442 0.143 −0.09407 0.071
Fasting plasma triglycerides - - 0.05707 0.004
Analysis of explanatory factors for supine pulse wave velocity (after logarithmic transformation) in multivariate analysis. The male sex, constrictor phenotype,
lowest BMI tertile, lowest age tertile, and BP < 135/85 mmHg served as reference categories in both models, i.e. for these variables the numeric value of the
coefficient is 0
Model 1 was based on phenotype, BMI-category, age-category, BP-category, and sex. Model 1 formula
for log(PWV) ~ Constant + phenotype + BMI-category + AGE-category + BP-category + sex + phenotype*sex
Example of interpretation: median log(PWV) for a woman with the sustainer phenotype with BMI and age in the highest tertile and BP ≥ 135/85 mmHg: 1.83258 +
0.09103 + 0.12824 + 0.23804 + 0.10273+ 0.03609 + (-0.07442) = 2.35429; median PWV = exp(2.35429) = 10.53 m/s
Model 2 was based on Model 1 and fasting plasma total, LDL, and HDL cholesterol, triglycerides, glucose, and haematocrit
Model 2 formula for log(PWV) ~ Constant + phenotype + BMI-category + AGE-category + BP-category + sex + phenotype *sex + 0.05707*plasma
triglyceride concentration
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[41–43]. The head-up tilt uncovered differences in car-
diac autonomic tone that largely resulted from the sup-
pression of cardiac parasympathetic tone (decrease in
HF power) in response to upright posture in the
intermediate and sustainer phenotypes (Fig. 4b). Subse-
quently, the sustainers showed the highest upright LF/
HF ratio, which corresponds to the smallest upright de-
crease in cardiac output in this phenotype. Previously,
sympathovagal imbalance in young prehypertensive sub-
jects has been attributed to increased sympathetic and
decreased parasympathetic tone [44].
Increased arterial stiffness is known to influence the
control of autonomic tone. Higher arterial stiffness has
been associated with reduced heart rate variability
(HRV) [45–47]. As baroreceptors are located in the ar-
terial wall, arterial stiffening attenuates baroreceptor re-
sponses to changes in BP [48]. Increased large arterial
stiffness and impaired cardiac baroreflex control are also
typical features of hypertension, and haemodynamic
changes in hypertensive subjects have been attributed to
reduced vagal inhibitory influence and overdrive of the
sympathetic nervous system (for a review, see [49]). Yet,
reduced baroreflex sensitivity in the elderly can persist
during methodological elimination of the influence of
the stiffness of the vessel wall [50]. Therefore, increased
arterial stiffness is not the sole explanation for baroreflex
changes, and these may also result from changes in the
control of neural baroreflex pathways [50].
In the present study, a putative explanation for the asso-
ciation between the sustainer phenotype and increased ar-
terial stiffness would be alterations in baroreflexes, and
this topic is a subject for further studies. However, it
should be noted that the differences in HF power and LF/
HF ratio were no more significant in adjusted analyses.
This indicates that the demographic differences (sex distri-
bution, BMI, and presence of hypertension) between the
phenotypes largely explained the observed deviations in
cardiac autonomic tone. Importantly, the differences in
PWV between the phenotypes persisted after the adjust-
ments, indicating that the deviations in autonomic tone
did not explain the differences in arterial stiffness. The
cross-sectional design of our study does not allow conclu-
sions about causality, and an unanswered question is
whether modifications in the associating risk profiles (like
weight reduction) would result in changes of the func-
tional cardiovascular phenotype.
Gender distribution was different between the pheno-
types, with male predominance in the sustainers. Previ-
ously, haemodynamic differences between men and
women have been observed in central wave reflections
[51], but the functional CV differences have been less
thoroughly characterized. In women, autonomic responses
to orthostasis may be attenuated due to lower barorecep-
tor sensitivity [52]. Smaller body size and lower centre of
gravity have been suggested to increase venous pooling of
blood to lower extremities in women during orthostatic
challenge [53]. In the present study, the decrease in car-
diac index during upright posture was greatest in the
Fig. 5 Heart rate variability in the 3 phenotypes. Boxplots depicting
low frequency (LF) power (a), high frequency (HF) power (b), and
LF/HF ratio (c) of heart rate variability in supine and upright
positions. Median (line inside box), 25th to 75th percentile (box), and
range (whiskers); *p < 0.05, **p < 0.01, ***p < 0.001
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constrictors with female predominance, which could
imply an increase in venous pooling of blood during head-
up tilt. However, BP was well maintained in the constric-
tors, probably due to the pronounced increase in vascular
resistance. Despite the differences in gender distribution
between the groups, PWV was significantly associated
with the functional phenotype, while the association of
PWV with sex was only found as an interaction in the
intermediate phenotype.
The present non-invasive methods have been validated
against invasive methods [23, 29, 54], and the repeatabil-
ity and reproducibility of the measurements are good
[22]. The non-invasive nature of the recordings is a limi-
tation, as the calculation of cardiac output from the
bioimpedance signal requires mathematical equations
and simplification of physiology [24]. Invasive haemo-
dynamic measurements, however, are not justified in
humans without a clinical reason. The tonometric meas-
urement of carotid-femoral PWV is considered as the
gold standard for the assessment of arterial stiffness
[55], and the lack of this method in our study can be
considered as a limitation. The impedance cardiography-
derived PWV shows good correlation with PWV mea-
sured with Doppler ultrasound [25], and the method has
also been found to be a practical approach for the evalu-
ation of arterial stiffness in 799 individuals aged 25–76
years [26]. The median BMI in the study population was
26.3 kg/m2, which corresponds to the average BMI in
Finnish men (27.4 kg/m2) and women (26.9 kg/m2) in a
large Finriski 2007 survey [56]. The present median of-
fice BP (138/89 mmHg) was slightly lower than the re-
ported average BP in the Finnish population (145-148/
85-90 mmHg) [57]. Importantly, subjects taking medica-
tions with known influences on haemodynamics were
excluded from the present study.
Conclusions
We found that subjects could be classified to 3 pheno-
types according to the head-up tilt –induced changes in
CV function. Independently of other risk factors, the
sustainer and the intermediate phenotypes were associ-
ated with increased large arterial stiffness. Evaluation of
cardiac autonomic tone showed increased supine and
upright sympathovagal balance in the sustainer pheno-
type. The present results suggest that the functional
phenotype of the haemodynamic response to upright
posture is associated with arterial stiffness and thus also
with the level of CV risk. Future follow-up studies with
CV end-points are needed to demonstrate the clinical
relevance of the present phenotypic information.
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